Beam Therapeutics Inc. Common Stock (BEAM) Financials
Key financial figures for Beam Therapeutics Inc. Common Stock (Q2 2026).
- Revenue
- $490K
- Net Income
- -$123M
- EPS
- $-1.18
- Total Assets
- $1.4B
- Operating Cash Flow
- -$66M
Full income statement, balance sheet, and cash flow for Beam Therapeutics Inc. Common Stock on SentiSense.